147 related articles for article (PubMed ID: 37257142)
21. High-cost imaging in elderly patients with stage IV cancer.
Hu YY; Kwok AC; Jiang W; Taback N; Loggers ET; Ting GV; Lipsitz SR; Weeks JC; Greenberg CC
J Natl Cancer Inst; 2012 Aug; 104(15):1164-72. PubMed ID: 22851271
[TBL] [Abstract][Full Text] [Related]
22. Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment.
Cooper GS; Yuan Z; Stange KC; Dennis LK; Amini SB; Rimm AA
Med Care; 2000 Apr; 38(4):411-21. PubMed ID: 10752973
[TBL] [Abstract][Full Text] [Related]
23. Utility of the SEER-Medicare data to identify chemotherapy use.
Warren JL; Harlan LC; Fahey A; Virnig BA; Freeman JL; Klabunde CN; Cooper GS; Knopf KB
Med Care; 2002 Aug; 40(8 Suppl):IV-55-61. PubMed ID: 12187169
[TBL] [Abstract][Full Text] [Related]
24. Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer.
Onukwugha E; Yong C; Hussain A; Seal B; Mullins CD
BMC Med Res Methodol; 2014 Jan; 14():1. PubMed ID: 24383436
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Machine Learning Methods With Traditional Models for Use of Administrative Claims With Electronic Medical Records to Predict Heart Failure Outcomes.
Desai RJ; Wang SV; Vaduganathan M; Evers T; Schneeweiss S
JAMA Netw Open; 2020 Jan; 3(1):e1918962. PubMed ID: 31922560
[TBL] [Abstract][Full Text] [Related]
26. Out-of-pocket cost by cancer stage at diagnosis in commercially insured patients in the United States.
McGarvey N; Gitlin M; Fadli E; Chung KC
J Med Econ; 2023; 26(1):1318-1329. PubMed ID: 37907436
[TBL] [Abstract][Full Text] [Related]
27. Cancer stage at diagnosis and survival among persons with Social Security Disability Insurance on Medicare.
McCarthy EP; Ngo LH; Chirikos TN; Roetzheim RG; Li D; Drews RE; Iezzoni LI
Health Serv Res; 2007 Apr; 42(2):611-28. PubMed ID: 17362209
[TBL] [Abstract][Full Text] [Related]
28. Potentially inappropriate medication use in older patients with breast and colorectal cancer.
Karuturi MS; Holmes HM; Lei X; Johnson M; Barcenas CH; Cantor SB; Gallick GE; Bast RC; Giordano SH
Cancer; 2018 Jul; 124(14):3000-3007. PubMed ID: 29689595
[TBL] [Abstract][Full Text] [Related]
29. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.
Sanoff HK; Carpenter WR; Martin CF; Sargent DJ; Meyerhardt JA; Stürmer T; Fine JP; Weeks J; Niland J; Kahn KL; Schymura MJ; Schrag D
J Natl Cancer Inst; 2012 Feb; 104(3):211-27. PubMed ID: 22266473
[TBL] [Abstract][Full Text] [Related]
30. Trends in Sociodemographic Disparities in Colorectal Cancer Staging and Survival: A SEER-Medicare Analysis.
Liang PS; Mayer JD; Wakefield J; Trinh-Shevrin C; Kwon SC; Sherman SE; Ko CW
Clin Transl Gastroenterol; 2020 Mar; 11(3):e00155. PubMed ID: 32352722
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis date agreement between SEER and Medicare claims data: impact on treatment.
Lin CC; Virgo KS
Med Care; 2014 Jan; 52(1):32-7. PubMed ID: 24322987
[TBL] [Abstract][Full Text] [Related]
32. Measuring breast, colorectal, and prostate cancer screening with medicare claims data.
Freeman JL; Klabunde CN; Schussler N; Warren JL; Virnig BA; Cooper GS
Med Care; 2002 Aug; 40(8 Suppl):IV-36-42. PubMed ID: 12187166
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of irinotecan-based chemotherapy regimens in elderly Medicare patients with metastatic colorectal cancer.
Obeidat NA; Pradel FG; Zuckerman IH; DeLisle S; Mullins CD
Am J Geriatr Pharmacother; 2009 Dec; 7(6):343-54. PubMed ID: 20129255
[TBL] [Abstract][Full Text] [Related]
34. Factors Contributing to Delay in Specialist Care After Colorectal Cancer Diagnosis in Kentucky.
Chow Z; Osterhaus P; Huang B; Chen Q; Schoenberg N; Dignan M; Evers BM; Bhakta A
J Surg Res; 2021 Mar; 259():420-430. PubMed ID: 33092860
[TBL] [Abstract][Full Text] [Related]
35. Spatially varying effects of predictors for the survival prediction of nonmetastatic colorectal Cancer.
Tian Y; Li J; Zhou T; Tong D; Chi S; Kong X; Ding K; Li J
BMC Cancer; 2018 Nov; 18(1):1084. PubMed ID: 30409119
[TBL] [Abstract][Full Text] [Related]
36. Is ulcerative colitis associated with survival among older persons with colorectal cancer in the US? A population-based case-control study.
Shaukat A; Salfiti NI; Virnig DJ; Howard DH; Sitaraman SV; Liff JM; Lederle FA
Dig Dis Sci; 2012 Jun; 57(6):1647-51. PubMed ID: 22113428
[TBL] [Abstract][Full Text] [Related]
37. Associations between initiating antihypertensive regimens on stage I-III colorectal cancer outcomes: A Medicare SEER cohort analysis.
Balkrishnan R; Desai RP; Narayan A; Camacho FT; Flausino LE; Chammas R
Cancer Med; 2021 Aug; 10(15):5347-5357. PubMed ID: 34184420
[TBL] [Abstract][Full Text] [Related]
38. Use of Medicare claims data to measure county-level variations in the incidence of colorectal carcinoma.
Cooper GS; Yuan Z; Stange KC; Rimm AA
Cancer; 1998 Aug; 83(4):673-8. PubMed ID: 9708930
[TBL] [Abstract][Full Text] [Related]
39. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
[TBL] [Abstract][Full Text] [Related]
40. The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening.
Gross CP; McAvay GJ; Krumholz HM; Paltiel AD; Bhasin D; Tinetti ME
Ann Intern Med; 2006 Nov; 145(9):646-53. PubMed ID: 17088577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
